Expressions and significance of sFas and FasL in the peripheral blood of patients with malignant hematopathy

HUANG Yingqi; SUN Suping; REN Min; SHAN Zhe; HAN Wenmin

doi:10.7619/jcmp.201419011

Cite
Share

facebook

twitter

google

linkedin

Journal of Clinical Medicine in Practice > 2014 > (19): 34-37. > DOI: 10.7619/jcmp.201419011

HUANG Yingqi, SUN Suping, REN Min, SHAN Zhe, HAN Wenmin. Expressions and significance of sFas and FasL in the peripheral blood of patients with malignant hematopathy[J]. Journal of Clinical Medicine in Practice, 2014, (19): 34-37. DOI: 10.7619/jcmp.201419011

Citation:

HUANG Yingqi, SUN Suping, REN Min, SHAN Zhe, HAN Wenmin. Expressions and significance of sFas and FasL in the peripheral blood of patients with malignant hematopathy[J]. Journal of Clinical Medicine in Practice, 2014, (19): 34-37. DOI: 10.7619/jcmp.201419011

Citation:

HUANG Yingqi, SUN Suping, REN Min, SHAN Zhe, HAN Wenmin. Expressions and significance of sFas and FasL in the peripheral blood of patients with malignant hematopathy[J]. Journal of Clinical Medicine in Practice, 2014, (19): 34-37. DOI: 10.7619/jcmp.201419011

Expressions and significance of sFas and FasL in the peripheral blood of patients with malignant hematopathy

More Information

Published Date: January 13, 2015

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Expressions and significance of sFas and FasL in the peripheral blood of patients with malignant hematopathy

Catalog

Export File

Citation

Format

Content